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TECHNICAL ISSUES RELATING TO AGRICULTURAL MICROBIAL GENETIC 
RESOURCES (AMIGRS), INCLUDING THEIR CHARACTERISTICS, UTILIZATION, 
PRESERVATION AND DISTRIBUTION 
 
A DRAFTINFORMATION PAPER PREPARED FOR THE GENETIC RESOURCES POLICY 
COMMITTEE (GRPC) OF THE CGIAR 
EXECUTIVE SUMMARY 
PART 1 
[ES.1] Plants and animals can not grow optimally without microbes, and 90 percent of flowering 
plants form some association with microbes to enhance their growth. Biological Nitrogen Fixation 
(BNF), for example, is one of the most important biological processes on the planet, turning inert 
nitrogen gas from the air into a form that plants and animals can use to make protein.  
[ES.2] Agricultural Microbial Genetic Resources (AMiGRs) may be defined as microbes that assist 
the production of plants or animals, either directly or indirectly, in agricultural settings. AMiGRs can 
be differentiated from Microbial Genetic Resources (MGRs) utilized in food, medicine and industry, 
but for many this can only be upon the basis of their functionality (or end-use), as species overlap both 
categories. AMiGRs have been preserved in a series of ex situ repositories associated with institutions 
or individuals around the globe, in more modern times as freeze dried or frozen (-80°C) cultures.  
[ES.3] After root nodule bacteria (RNB), the most preserved microbes appear to be pathogenic 
fungi and bacteria that are used as type specimens in breeding efforts. Germplasm repositories for 
bacteria, in particular, have embraced lyophilization as the preferred storage method.  
[ES.4] There is evidence that germplasm collections are discarded as the key curator retires, 
particularly if the germplasm is not freeze dried. Only about half the germplasm repositories surveyed 
seem to have an accessible electronic database. 
[ES.5] The development of a series of in situ plant repositories coordinated by ICARDA in West 
Asia provides an opportunity for associated preservation of AMiGRs for plants and insects, but 
perhaps not for animal microbes. The AMiGRs most likely to be successful are those that are 
endophytic (i.e. they invade host tissue) because organisms that only colonize the surface of the target 
are often non-competitive against microbes already well adapted to that environment 
[ES.6] AMiGRs have been used since antiquity, but they have only been properly scientifically 
described since the late 19th and early 20th centuries, and this process is ongoing  
[ES.7] Many currently exploited AMiGRs evolved in developing countries, but were transported to 
alien shores by accident through contamination of plants, animals or fodder, or in jet-streams. 
AMiGRs are considered in some quarters to be the ‘bio-prospecting’ entities of tomorrow, as plants 
are today. International coordination of genetic resources has yet to focus upon, or manage, AMiGRs. 
There is uncertainty whether AMiGRs utilized today can be reliably traced to their origins, even with 
the genetic techniques now available. 
[ES.8] RNB seem to have been de-emphasized in the CGIAR system in the last decade, perhaps 
because many consider the work with them to have been completed. However, there appears to be 
continuing advances with RNB in other agricultural economies. It seems incongruous that many 
projects are built around microbial germplasm repositories that are uniformly poorly resourced. Some 
countries, such as China, India and the former Soviet Union, have a cultural history of utilizing 
AMiGRs, and this is becoming reflected in the nature of the AMiGRs held by some CGIAR centres. 
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PART 2 
[ES.9] It is complex to assess the needs of, or potential benefits from, applying AMiGRs in 
agriculture because responses are often species and environment specific. This is the greatest 
challenge in embracing AMiGRs. AMiGR usage in developing countries is often limited by lack of 
manufacturing capacity and quality control. This needs to be addressed. Developing countries often 
subsidize imported N[itrogen] fertilizer to make this affordable for their farmers. An alternative is to 
develop RNB. A global benefit of this is that legume N fixation does not contribute to greenhouse gas 
emissions, whereas the manufacture of 1 tonne of urea burns 1 tonne of fossil fuels.  
[ES.10] AMiGR adoption in developing countries would benefit from the availability of a ‘core set’ 
of AMiGRs with which to experiment. This would remove the initial time-consuming need to 
authenticate cultures and to establish their phenotype. A core set of AMiGRs could readily be 
developed by scientists who have collaborated in microbial germplasm exchange and evaluation 
programmes with the CGIAR centres. Countries that hold AMiGRs, for example in in situ 
repositories, may not yet be exploiting them, and thus the cost of conserving germplasm is borne by 
them for no immediate reward. Developed countries are prominent users of AMiGRs, mainly RNB, 
but they distribute a narrow range of organisms over vast acreages, and this has implications for loss 
of microbial biodiversity in these regions. 
[ES.11] It is difficult to foresee where (geographically) the next range of exploitable microbes may 
arise. For example, Australia’s microbes may become globally useful in bioremediation, and hence her 
current role as a net user of agricultural genetic resources (without contributing to the cost of their 
preservation) might well be reversed. Although the usage of AMiGRs in some agricultural systems 
might be routine (e.g. RNB), and the benefit of this application may be high (as estimated by the 
monetary cost of replacing N fixed by RNB with fertilizer N), the wholesale value of manufactured 
microbes is much lower, and thus any royalties levied on production are not likely to be of high value. 
The major obstacles to uptake of AMiGRs in developing countries are discovering, preserving and 
cataloguing the available AMiGR biodiversity, accurately ascertaining the beneficial properties of any 
AMiGR, and then manufacturing, distributing and utilizing high quality inoculants. 
[ES.12] The USDA has moved to centralization of curatorial responsibility for MGRs in the USA. 
There is evidence that South American countries are utilizing this centralized facility. It could be 
possible to assign curatorial responsibility for one mainstream group of AMiGRs to each continent. 
[ES.13] There has emerged an ‘official’ approach to acquisition and exchange of AMiGRs over the 
last decade, with Material Transfer Agreements (MTAs) and Memoranda of Understanding (MOUs) 
covering acquisition and exchange as well as future control of any commercial outcomes. 
[ES.14] The taxonomy of microbes, particularly bacteria, in the 21st century, is unsettled. It is 
difficult to develop standards for the identification for many microbes, except for type strains whose 
genome is fully sequenced. AMiGRs may be separated from MGRs on the basis of functionality, but 
there is overlap, and for some microbes this distinction may have to be at the species level. AMiGRs 
are delivered live, whilst MGRs generally transform a process and are then eliminated—a major 
difference between AMiGRs and MGRs that can influence the possibility of obtaining and enforcing 
patents for MGRs used in food, medicine and industry. The situation for AMiGRs is clouded by their 
rapid rate of reproduction, and potential change during culture. 
[ES.15] Quarantine and biosecurity concerns are reducing the extent of germplasm exchange, more 
so than issues of ‘ownership’. Commercial entities in the 21st century are patenting AMiGR 
manufacturing and delivery technologies, rather than the microbes themselves. This reflects that a 
major challenge in utilization of AMiGRs is the development of appropriate manufacturing and 
delivery technologies. 
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PART 1 
I. INTRODUCTION: HISTORICAL PERSPECTIVE 
[1] Although the Romans wrote of the beneficial effects of cultivating nitrogen-fixing legumes 
such as lupins and pulses in rotation with cereals, the deliberate utilization of microbes in agriculture 
awaited the advances in manufacturing technologies that were developed towards the end of the 
19th century. The invention of fine instrumentation for observing microorganisms, the subsequent 
development of specific growth media and then microbe purification enabled the microscopic world to 
be studied in detail. The root nodule bacteria (RNB) for legumes were almost certainly the first group 
of agricultural microbes to be studied at the microscopic level, and this was in the same decade that 
proof emerged (in 1883) that microbes such as Vibrio spp. were the causative agents of serious human 
and animal illnesses, such as cholera. RNB were, in fact, manufactured as agricultural amendments 
within a few years of Beyerinck isolating and growing the bacteria, and Wilfarth and Hellriegel 
identifying their role in legume nodulation and nitrogen fixation in 1887. This was only 6 years after 
Koch first cultured bacteria on gelatin. The early adoption of RNB inoculants was achieved by 
transferring soil from field to field, or soil to seed before planting, but this was quickly replaced by the 
supply to farmers of pure cultures on agar slants, then as broths. The first inoculant industries for RNB 
developed in the 1920s, with peat carriers available from the 1950s (Deaker et al. 2004). Global 
inoculation of legumes with RNB is valued at in excess of US$ 10 billion annually (calculated on the 
basis of the cost of replacing RNB-fixed N with manufactured N; Herridge 2005). This equation does 
not include the additional benefit that legume N fixation is a net user of greenhouse gases, whereas the 
manufacture of fertilizer N is energy demanding, and thus a net producer of greenhouse gases.  
[2] Concomitant with the isolation of RNB from nodules, the understanding of the diversity of 
microbes interacting in symbioses with plants was expanded with the discovery of the relationship 
between certain fungal hyphae and plant nutrient acquisition. Frank described the fungus-root 
interaction with mycorrhizae in 1885, and it is now realized that about 95 percent of all vascular plants 
are involved in symbiotic associations with fungi. The most notable of these roles is with vesicular 
arbuscular mycorrhizae (VAM) and ectomycorrhizae in the acquisition of phosphate. It was not long 
into the 20th century before the role of the soil microflora in the development of plant disease and also 
in nutrient cycling in the soil ecosystem could be quantified. The concept of the ‘rhizosphere’ and its 
role in plant growth was described in the 1950s, and the capacity for rhizosphere organisms to affect 
plant growth by hormone production, diazotrophy (non-symbiotic N fixation) or nutrient acquisition 
reported soon after. Rumen microbiology had become a discrete science by the 1970s, and the 
molecular communication between microbes and plant roots (or animal cells), leading to regulation of 
gene cascades, was revealed in the 1980s. The latest phase in the discovery of microbes as plant 
symbionts is in their role as intercellular endophytes. Within (or between) plant cells, secondary 
metabolites from endophytic microbes elicit plant responses. The best described of these associations 
is with Aceotobacter sp. in Brazilian sugar-cane systems, which has the capacity to provide N in 
excess of 30 kg/ha. Unfortunately, difficulties with culturing the endophytic VAMs (for phosphate 
acquisition) has restricted their widespread adoption. 
[3] It is now accepted that without these multiple aspects of microbial activity in the soil and 
rhizosphere, as well as in plant and animal tissues or cells, healthy plant and animal growth would not 
be possible. However, another facet of AMiGRs which is in a phase of development is in the use of 
microbes as indirect agents of plant growth (i.e. restricting a competitor or predator, rather than as 
plant symbionts or initiators per se). Thus, we now see a range of AMiGRs being considered as 
biocontrol agents for crop insects (e.g. Metarhizium spp.; nuclear polyhedrosis viruses) and fungal 
plant pathogens (e.g. Bacillus subtilis) to protect crop plants from disease. This field is termed 
‘entomopathogenicity’ and there are several registered products currently on the market. One of these, 
Metarhizium anisopliae, has been used successfully to avert grasshopper plagues developing in 
outback Australia, prior to them moving towards farmers’ crops. This sort of application of AMiGRs, 
together with RNB, entomopathogens and VAM, has great potential in developing countries. It is 
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worth noting here the historical widespread use of two classes of AMiGRs in China, India and the 
former USSR: organisms that stimulate root growth through hormone production or through 
diazotrophic N production, commonly termed ‘yield increasing bacteria’ (YIB), have gained 
substantial acceptance in the rural communities of these nations.  
[4] Thus, AMiGRs have been used, in one way or another, since antiquity, with the science of 
their interactions with plants, insects and animals only elucidated in the last 125 years. There is still 
much to learn about the microbes that enhance and protect animal growth in both natural and 
agricultural settings. 
II. SCOPE OF THE REVIEW 
[5] The scope of the review was defined by the Terms of Reference (see Appendix 4).  
III. MICROBIAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE AS A 
DISTINCT SUBSET OF MICROBIAL GENETIC RESOURCES 
[6] Following the development of RNB as inoculants in the late 19th century, other microbes are 
now applied in agriculture, in a relatively wide variety of roles. These disparate roles can be 
summarized from a functional perspective, and then compared with microbes used in food, industrial 
processes and in medicine production. Differences between the two groups of microbes are 
considered, and there is a discussion of how effectively we have captured these roles to enhance 
agricultural production. 
[7] The main functional roles of microbes in agriculture are considered to be as: 
• plant microsymbionts; 
• associative organisms (i.e. eliciting or enhancing a positive reaction or effect when in intimate 
proximity to a plant or animal); 
• rumen organisms; 
• biocontrol agents (pathogens of weeds, fungi, insects or nematodes); 
• pathogens of plants or animals; 
• agents for nutrient solubilization, bioremediation or biodegradation; 
• agents for production of biofuels; or 
• agents facilitating DNA or gene transfer. 
Examples of some AMiGR within these functional roles are given below, with more details to be 
found in Appendix 1. 
Plant microsymbionts (specifically RNB) — overwhelmingly the most successful AMiGR in agriculture 
[8] RNB, like legumes, are found on all continents. The RNB nodulate the Leguminosae, which is 
one of the largest families of flowering plants, with more than 18 000 species classified into 650 
genera (Sprent, 2001), just under one-twelfth of all known flowering plants. RNB tend to colonize the 
soils in association with their host legumes, although there is speculation (and indeed evidence) that 
some species of RNB ‘invade’ soils well in advance of their host. Not all the legumes fix atmospheric 
N, however, and amongst the subfamilies of the Leguminosae, the species within the Fabaceae are 
recognized as those of greatest agricultural importance. Some of our most valuable food crops, such as 
pea (Pisum spp.), beans (Phaseolus spp.), ground-nut (Arachis spp.) and soybean (Glycine spp.) are 
Fabaceae, producing high-protein grains for human consumption. Of all the plants that man uses for 
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food, perhaps only the grasses (Graminiae) are more important than the legumes (Graham and Vance, 
2003).  
[9] The symbiotic association between RNB and legumes plays a significant role in world 
agricultural productivity by annually converting approximately 100 million tonnes of atmospheric 
nitrogen into ammonia (Herridge and Rose, 2000), and saving $US 10 billion in fertilizer N. This is a 
critical issue, as many countries (both developing and advanced) have not fully embraced biological 
nitrogen fixation and are substantially reliant upon fertilizer nitrogen. This lack of adoption of RNB is 
attributed to many factors: from a lack of knowledge and expertise in growing and inoculating 
legumes with rhizobia (Giller, 2001), to government subsidies in both developing and advanced 
economies that militate against the use of biological nitrogen fixation. Sadly, with the price of fossil 
fuels inevitably increasing, small economies will be faced with either food shortages or an inflated bill 
for fertilizer N. Many developing countries rely upon buying urea for rice production (Thein and Hein, 
1997). Their declining purchasing power in real terms will be deleterious for food production; this 
must be addressed, as current reviews forecast that food production will need to double by 2020 to 
feed our expanding population (Byerlee and White, 2000).  
Vesicular arbuscular mycorrhizae (VAM) and ectomycorrhizae 
[10] Approximately 90 percent of all flowering plant species belong to families that form 
mycorrhizal associations. Mycorrhizae can be either endophytic (exist within cells) or grow between 
cells (ectophytic) of plant roots. Both patterns of development can be viewed as providing an 
extension of the plant root systems for the purpose of exploring a greater soil volume for nutrient 
uptake. Mycorrhizae and their interactions profoundly affect forest site productivity through capture 
and uptake of nutrients, protection against pathogens, maintenance of soil structure and buffering 
against moisture stress. The nutrients that are most often limiting plant growth are fixed nitrogen (N) 
and phosphorus (P), and it is for alleviating deficiencies of the latter that mycorrhizae have proven 
efficacious. Where soil P levels fall to 1 or 2 ppm, plant growth is usually constrained. Unfortunately, 
many heavily leached tropical soils are at or below this level and it is in these environments, as well as 
in severely eroded regions, that applications of mycorrhizae can be effective. Although the VAM are 
difficult to culture, they are the preferred type of inoculant, so we see cottage industries in tropical and 
subtropical countries where soils containing VAM are used to inoculate trees in nursery situations. 
When planted out into degraded lands, the VAM-inoculated seedling trees have a distinct advantage 
over uninoculated trees. VAM utilization has not spread to broad-acre crops for two main reasons. 
Firstly, it is difficult to inoculate crops with soil containing VAM over wide acreages, and, secondly, P 
fertilizers can effectively replace VAM. Despite this, VAM is a bona fide AMiGR in horticulture and 
forestry applications, and in rehabilitation exercises. 
Microalgae, including Cyanobacteria 
[11] Cyanobacteria (formerly termed blue-green algae) are photosynthetic prokaryotes, usually 
unicellular, some of which have the capacity to fix atmospheric nitrogen. The capacity of 
Cyanobacteria to fix N has long been utilized in paddy rice fields to provide additional N to the rice-
growing system, reducing the need to supply all the crop N requirements from combined fertilizer. 
The Cyanobacteria utilize the water and phosphorus applied to the rice crop, and sunlight as an energy 
source. The species of Cyanobacteria most commonly utilized in paddy fields is the filamentous algae 
Nostoc spp., which forms a symbiotic association with the water fern Azolla in paddy fields. Nostoc 
spp. may also associate with Gunnera spp. and the terrestrial Cycads. Nostoc spp. has been 
transformed by the addition of Bacillus thuringiensis (Bt) genes to investigate the potential of this alga 
to control insects in rice production. 
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Associative organisms: Plant Growth Promoting Rhizosphere (PGPR) organisms or Yield Increasing 
Bacteria (YIB) 
[12] China, India and the former Soviet Union have a long history of experimenting with, reporting 
and even manufacturing microbes that can be classified as PGPR or YIB. These microbes fit within 
functional group 2 (see Figure 1). The microbes are generally bacteria that form close associations 
with plant root systems, but may also be actinomycetes, fungi or endophytes. As a result of a plentiful 
supply of nutrients exuded from the roots in the rhizosphere, the PGPR have the capacity to grow and 
produce of enzymes such as ACC deaminase, whose action reduces the production of ethylene under 
stress conditions. Hormones, such as indole acetic acid (IAA), which affect root growth, branching 
and hair formation, are also commonly produced by PGPR, together with some N fixation (albeit in 
small amounts). There are many more mechanisms in which PGPR may benefit their hosts, from 
disease protection, nutrient solubilization to controlled exchange of mutually desirable proteins. With 
the cloning era, it has become possible to investigate more elaborately the relationship between PGPR 
and the host plant, and it is becoming obvious that many of the relationships are established by a 
complex pathway of low molecular weight (LMW) biochemical signals that control gene expression.  
[13] Many of the commonly reported PGPR microorganisms are ubiquitous and it is possible to 
isolate them from garden, farm and forest soils. Because of the ease of isolation of the common PGPR, 
there is little exchange of this sort of germplasm per se. For those more difficult to culture, such as the 
actinomycetes and endophytes, there is substantial laboratory-to-laboratory exchange. Appendix 1 
contains descriptions of some of the microbes commonly referred to as PGPR. The Pseudomonads 
have been used extensively in broad-acre agriculture for many years, but there is very little hard and 
convincing data that proves yield enhancement from their application. Similarly, Penicillium spp. have 
been developed as agents for solubilization of soil-bound phosphate, although modern studies have 
questioned this role and attributed their efficacy to direct impacts on plant growth. 
Rumen organisms 
[14] Some animals have a second stomach called the rumen, in which a suite of microbes assist in 
the breakdown of otherwise indigestible forages. The best researched rumen microbes are those that 
enable the digestion of forage containing high tannin levels, but other rumen microbes enhance fibre 
and cellulose digestion, and mitigate anti-nutritional factors. In cellulose degradation, a complex suite 
of microbial-mediated actions is initiated by anaerobic prokaryotes and protozoans, which liberate 
carbohydrates from cellulose. The carbohydrates are then fermented to gaseous end products. There is 
continuing research to select rumen microbes that minimize the release of methane (a greenhouse gas) 
to the atmosphere. The rumen microbes eventually overflow into adjacent stomach compartments, 
where their degradation by stomach acids yields amino acids and sugars that provide animal nutrition. 
Apart from minimizing methane production, other research interests include modifying the rumen 
microflora to metabolize toxic compounds found in some forages, such as the fluoroacetate found in 
many legumes. There is evidence that the rumen microflora can naturally evolve in response to the 
nutritional environment of their host, and that this response can be transferred from animal to animal.  
Biocontrol agents, such as Metarhizium anisopliae (an insecticide), Bacillus subtilis (a fungicide) and 
B. thuringiensis (an insecticide) 
[15] There are approximately 15 different biopesticides in current commerce, with Bacillus 
thuringiensis (Bt) accounting for approximately 45 percent of the market. A related species, B. subtilis, 
has been developed as a root-active fungicide, for protecting horticultural plants from pathogens. 
B. subtilis is sold as a fungicide for application to flower and ornamental seeds, and to agricultural 
seeds including cotton, vegetables, ground-nut and soybean. The bacterium colonizes the developing 
root system of the plant and competes with fungal disease organisms. The fungal genus Metarhizium is 
another AMiGR that has long shown promise as an insecticide. The successful mass culture of 
M. anisopliae and development of methods of mass-producing infective spores has led to the 
commercial uptake of this fungus as a microbial ‘insecticide’. M. anisopliae is grown on a large scale 
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in semi-solid fermentation and the spores are then formulated as a dust suspended in oil. This may be 
aerially applied to insect plagues. In Australian trials, application of M. anisopliae from aircraft in 
remote Queensland controlled a developing locust plague by killing 90 percent of the insects. 
Pathogens of plants or animals 
[16] Plant and animal pathogens need to be considered as AMiGRs because they are held in 
germplasm collections to facilitate breeding or selection programmes to find resistance to them. For 
plants, the pathogens are dominantly fungi, bacteria and viruses, most of which are ubiquitous at the 
genus level, but many of which have distinctive ‘landraces’ that are geographically separated. The 
transport of agricultural plants and animals to new geographical locations is now strictly regulated to 
control transfer of such pathogens, yet it appears the transfer of pathogenic microbes eventually 
follows the movement of their hosts. For example, the development of Cicer arietinum (chickpea) as 
an industry in Australia flourished in the early 1990s, but has since been seriously constrained by the 
development of Ascochyta blight disease, which was previously unrecorded in that country. There has 
been substantial success in managing the unwanted transfer of animal pathogens. For example, the 
Foot-and-Mouth virus, in the genus Aphthovirus, has been effectively excluded from many major meat 
producing regions by restrictive quarantine efforts. 
AMiGRs as agents for nutrient solubilization, bioremediation or biodegradation 
[17] This group of AMiGRs can be considered as separate from the associative organisms in 
Functional group 2 (Figure 1) principally because they interact with inanimate and inorganic targets 
(in contrast to the plants or animals that host the associative microbes). Targets for this group of 
AMiGRs include the (substantial) pool of inorganic phosphate held in the soil, toxic chemicals 
inadvertently accumulated or deposited in the soil, such as DDT, heavy metals and fossil fuels. 
AMiGR for production of biofuels 
[18] Biofuels, such as ethanol, have been considered an expedient alternative to fossil fuels since 
the petroleum fuel crisis of the 1970s. Essentially, carbohydrates derived from sugar-rich plants such 
as cassava, sugar beet or sugar-cane are fermented to ethanol by yeast in anaerobic respiration, but 
also occasionally by some bacteria. These microbes might be considered as AMiGRs because of their 
strong linkages to broad-acre agricultural enterprises. 
AMiGRs facilitating DNA or gene transfer 
[19] Although bacteria have been exchanging DNA since life formed on the planet, the cloning era 
began in earnest post-1985 with the deliberate laboratory transfer of whole genes, or parts of genes, 
between bacteria. Such transfer is now routine in many laboratories, between almost all higher 
lifeforms. There are universal vehicles for facilitating the transfer of DNA. The most common vectors 
in agricultural research are Agrobacterium spp. for plant-to-plant transfer and Escherichia coli for 
inter-bacterial transfer. Thus, these microbe vectors should be considered as AMiGRs because of their 
direct relevance to agricultural research. 
[20] Fuller descriptions of some of the microbes that fill these functional roles can be found in 
Appendix 1. It is noteworthy that by far the most successful AMiGRs in broad-acre agriculture appear 
to be those that are endophytic, i.e. they invade the tissues of their host, for all or part of their life 
cycle, rather than residing on the surface of the target plant or animal. On the surface they may 
become exposed to competition from resident organisms that are, perhaps, better adapted to that 
particular environment.  
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Grouping the AMiGR into functional roles 
[21] AMiGR may be broadly grouped as in Figure 1. Functional roles 6 and 7 in Figure 1 group 
together microbes that interact with nutrients, biomass or pollutants for bioremediation or fuel 
production. The beneficial symbiotic organisms (1, 3) can be grouped with those that also increase 
growth of plants or animals as associative microbes (2). The pathogens (4, 5) can be grouped, whether 
they are directly beneficial or not, because their modes of action are similar (i.e. they decrease growth 
of the target organism). These last-named two functional groupings (highlighted) contain those 
microbes that have seen major exploitation in agriculture. 
 
 
 
Figure 1. AMiGRs assigned to functional groups, with the highlighted groups being those most 
exploited in agriculture. 
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Figure 2. Functional groups of MGR added to those of AMiGR, and with an indication of areas of 
overlap with those used in Agriculture (thick bars). 
 
Microbes in food, medicine or industry 
[22] The main functional roles for microbes in food, medical science and industry (i.e. MGRs) are 
considered to be in: 
• fermentation of foods and beverages; 
• manufacture of medicines and pharmaceuticals; 
• gene or DNA transfer; or 
• mass culture as a source of pigments or antioxidants, or as a feed base for higher organisms. 
[23] Fuller descriptions of these functional roles can be found in Appendix 1, but for comparison 
they are placed alongside those used in agriculture in Figure 2.  
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Areas of overlap. How may the agriculturally relevant groups be best separated from those utilized in 
food or medicine? 
[24] There appear to be at least three functional roles that directly overlap between agriculture and 
either food, medicine or industry. The first is the use of microbes as agents for transfer of genes or 
DNA. Examples are E. coli and Agrobacterium spp., both of which are used extensively as carriers of 
plasmids holding DNA. Agrobacterium spp. is well described as a parasite of agricultural relevance. 
The second overlapping role is in microbes (usually microalgae) used in mass culture, that might also 
be associated with plants in agricultural settings. Specifically, microalgae can be utilized to produce 
pigments or antioxidants (e.g. beta-carotene, astaxanthin), fine chemicals (e.g. phycocyanin from 
Spirulina spp.) or to produce bulk feed in aquaculture industries (e.g. Chlorella spp.). However, the 
Cyanobacterium genus Nostoc is widely utilized to fix atmospheric nitrogen in association with rice 
production. Thirdly, there is significant overlap in the functions of fermentation for foods and 
associative organisms for plants. Microbe genera that overlap in these two groups include Penicillium 
spp. and Acetobacter spp., which are used in the production of fermented dairy products, as well as 
being important rhizosphere or endophytic microbes for plants. Yeasts, of course, are essential in 
fermentation of food and beverages, but are also a key microbe in the production of ethanol as a 
biofuel. 
[25] However, it might be pragmatic to delineate AMiGRs from MGRs on the basis of their role in 
primary production. Thus AMiGRs might be considered (vide Figure 1) as: 
“microbes that are utilized, directly or indirectly, to assist the production of plants or animals 
in agricultural settings” 
Adherence to this definition would separate those MGRs utilized for biomass production in 
aquaculture (e.g. microalgae) or for food fermentation from those microbes utilized in situ in 
agricultural settings. Microbes routinely used for gene or DNA transfer (such as E. coli and 
Agrobacterium spp.) and for fermentation would then overlap both sectors, as shown in 
Figure 2.However, can the groups realistically be separated in this way, or are the overlaps just too 
numerous? If we look further there are other areas of overlap in industry, where E. coli and 
Clostridium spp. are used in ethanol or butane production (which is a fermentation process), 
Penicillium spp., yeasts and E. coli are exploited in production of antibiotics, alkaloids, steroids, 
insulin and growth hormones (outside of agricultural settings), and Aspergillus spp. and Bacillus spp. 
produce enzymes utilized in food or health processes. All of these genera are, or may be, utilized as 
AMiGRs. The challenge in defining a distinct set of AMiGRs then becomes one of separating the 
functional groups at the species rather than the genus level. It is an outstanding question as to whether 
this enterprise is warranted.  
IV. THE PHYSICAL NATURE OF COLLECTIONS AND HOW THEY DIFFER 
[26] Microbe ‘collections’ can be considered as either in situ or ex situ. In situ collections may be 
of two types: 
• the remaining undisturbed areas of the globe where microbes evolved and remain to this day 
relatively undisturbed as a component of the natural biodiversity; or 
• in disturbed sites where, because of the general resilience of microbes, the perturbation to the 
environment has not eliminated them.  
There is some evidence that in perturbed sites, such as long-term polluted sites, the microbe 
populations have been enriched in those organisms capable of remediating the pollutants. 
[27] In both forms of in situ repository, the microbes are probably dependent upon some form of 
host interaction for their survival and multiplication, whether with plants, animals, insects or other 
microbes. Few microbes are competent saprophytes in isolation. 
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[28] Ex situ collections are of three major forms and the major difference from in situ repositories 
is that in these collections the microbe is usually cultured in pure form, in the absence of any host. The 
full metabolic requirements of the microbe must be met from artificial sources. Ex situ collections may 
be: 
• collections amalgamated and fostered in the care of an individual; 
• collections associated with institutions, and, more correctly, departments of institutions, which 
accept curatorial responsibility for them; or 
• in association with commercial entities that exploit the microbes. 
V. THE HISTORY AND ACTUAL GLOBAL PATTERNS OF DISTRIBUTION OF THESE 
ORGANISMS 
General considerations concerning AMiGR distribution and exchange patterns 
[29] Many AMiGRs are microscopic bacteria, or form spores, and it is difficult to contain such 
microbes geographically. As for pathogens, AMiGR will cross borders in aerosol form, in dirt or as 
unintentional contaminants. This re-distribution of microbes has been concomitant with exploration of 
the globe by man. The implications of this are that the geographical origin of many microbes is 
difficult to ascertain, and, further, that widespread application of an AMiGR will eventually lead to the 
widespread availability of that AMiGR. This is compounded by the fact that AMiGRs, unlike most 
microbes used in food reactions, are delivered to their target in a live state. Without a comprehensive 
and expensive border quarantine effort, it is unlikely that any unwanted re-distribution of an AMiGR 
could be prevented. For example, DNA is currently exchanged between laboratories through postal 
services by simply applying a small quantity of DNA to a sheet of paper and circling that spot on the 
letter. The recipient simply elutes the DNA from the paper and then amplifies it for use via the 
polymerase chain reaction (PCR) process. 
[30] CGIAR, university and institutional scientists have historically and routinely exchanged 
AMiGRs or components of them (plasmids, DNA) for centuries. Culture repositories around the globe 
now hold thousands of cultures that have been accumulated in this fashion. By doing so, the science 
and exploitation of AMiGRs has rapidly advanced. The implications of this are that whilst there has 
been valuable preservation of genetic material ex situ, control of AMiGR at the species level has 
become clouded. Further, the value of any particular AMiGR is attached overwhelmingly to its 
manufactured form rather than to its germplasm form. As an example of this, culture collections 
sometimes contain over 1000 representatives (strains) of an organism. Individuals of this collection 
only become valuable after special attributes of them are identified, and the strain subsequently 
commercialized. 
[31] In recognition of the above points, a policy of facilated exchange of AMiGR with a 
harmonized form of multilateral benefit sharing seems most practicable. Proof of geographical origin 
and of strain identity will, in many cases, be impossible to provide and thecosts of enforcing a rigid 
constrainment policy will also far exceed the value of the AMiGR, and will reduce the global 
exploitation of beneficial microbes. There may be some resistance to this approach by countries who 
perceive themselves as the countries of origin of AMiGRs. To counter this, the development of a core 
set of authenticated AMiGRs for facilitated distribution, with benefits flowing to developing countries 
in general, but not to particular suppliers, is suggested. 
[32] A policy of facilitated exchange of AMiGR must be seen as separate to individual country 
policies on microbial biosecurity, as those policies might logically be applicable to any manufactured 
product, or to importation and distribution of pathogenic microbes. 
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GLOBAL CHANGES 
Root Nodule Bacteria 
[33] Without doubt, the greatest global changes in RNB distribution have come about with man’s 
exploration of the world in the 18th century and then with their use as inoculants for legumes, 
particularly in the 20th century. Massive changes have occurred in the tropics, subtropics and warm 
temperate zones of Africa, Asia and America, where Glycine max (soybean) inoculated with 
Bradyrhizobium japonicum now dominates grain legume production. There is nearly 70 million tonne 
of inoculated soybean produced annually in the USA, in addition to 34 and 53 million tonne in 
Argentina and Brazil, respectively (USDA, 2005). This compares with the global trade in cool season 
grains of approximately 60 million tonne (Kelley et al., 2000), which suggests that soybean is 
probably the single largest traded legume commodity in the world. The RNB inoculants for this crop, 
which probably evolved in China, have thus been distributed over more than 150 million hectares of 
the Americas in the last 30 years. 
[34] Similarly to soybean in the Americas, large tracts of land have been cleared of their native 
vegetation in central Asia, temperate America and southern Australia and planted to cool season 
forage legumes from two main genera, Trifolium (clovers) and Medicago (medics). Again, the 
majority of these legumes have been inoculated at some stage in their production with (the AMiGR) 
RNB. The perennial forage M. sativa (alfalfa; lucerne) has wide adaptation to soil and climate and 
because of this has spread from its centre of origin (believed to be in the temperate zones of Persia) to 
become the dominant forage on all continents in the last three millennia, carrying its RNB with it. No 
perennial form of a Trifolium species has achieved such prominence. Annual clovers and medics were 
established across 25 million hectares of arable land throughout southern Australia in the 19th and 
20th centuries, with RNB inoculants available since 1896. As for the tropics, this represents a massive 
global change in distribution of RNB. 
[35] At the same time, despite these examples of success in legume breeding and adoption, it is of 
concern that there are perhaps only 50 species of forage legumes and less than 15 species of grain 
legumes in wide global commercial trade (Kelley et al., 2000). Is it prudent, from a gene conservation 
perspective, to cover the globe so completely with only 65 of a potential 18 000 species of legume 
inoculated with only relatively few strains of RNB? We have evidence that these inoculants displace 
the original RNB. What is this doing to the in situ conservation of AMiGR biodiversity? 
[36] The Australian usage of RNB AMiGR provides a good example for analysis of some of the 
issues relevant to this review. The value of RNB to Australian agriculture is estimated at 
AUD$ 3 billion annually, in terms of N fixed estimated by the replacement cost of N as urea fertilizer. 
All of this N fixation is by strains that were originally exotic to Australia, originating from the 
Mediterranean basin and western Asia for the temperate strains, and a range of tropical origins, 
including Africa and South America, for the tropical inoculants. Further, almost all of the strains that 
are commercially manufactured in Australia and that have been developed over the last 40 years have 
come from germplasm collected either in situ in focused collection missions, or ex situ from 
genebanks. This suggests a commercial exploitation of AMiGR by Australian agriculture from 
resources held by developing countries. However, the manufacturing industry that produces these 
inoculants has a wholesale value of less than AUD$6 million. Thus, the $3 billion benefit accrues from 
a $6 million industry, and it is the latter from which returns could be made to the country of origin of 
these inoculants. However, there is one pertinent example in this scenario that cannot be ignored. The 
lupin inoculant accounts for over 55 percent of RNB sales in Australia. The strain utilized, WU425, 
was originally isolated from naturalized serradella nodules found in Western Australia. It is believed 
that both the serradella and the rhizobial strain arrived by accident on Australian shores in the 
19th century transport of animal fodder. This illustrates the difficulty of attempting to manage AMiGR 
movements around the globe, because microbes have moved accidentally with the development of 
global shipping. To reinforce this, recent genetic analysis of 50 lupin nodule isolates from Western 
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Australian fields examined by Thomas Strepkowski in Poland revealed that all of the isolates were 
from Europe, and that none had been deliberately introduced to Australia. 
[37] So managing AMiGR exploitation by developed countries in such a way that the country(ies) 
of origin of the microorganism (often developing countries) may benefit faces dual difficulties, namely 
that: 
• the value of AMiGR manufacture may be several orders of magnitude less than the value of their 
impact; and 
• AMiGR (and pathogens) demonstrably transit country borders unaided 
[38] This example of lupins in Australia is paralleled by that of soybean in the USA and South 
America, i.e. the current commercial inoculant strains evolved outside the geographical boundaries of 
these countries (actually in China), and were unintentionally transmitted to the New World, originally 
as contaminants on seed or in trash. All three soybean inoculants in America came from isolates made 
from naturalized soil populations. A similar scenario exists with alfalfa (lucerne). The movement of 
plant pathogens such as rusts (Puccinia spp.) and blights (e.g. Phytopthera spp.) from continent to 
continent is strong evidence for microbial transfer in aerosol form via the stratosphere. 
[39] The scenario with newly developed legumes and their inoculants differs from the examples 
given above. In Australia there has arisen a ‘second generation’ of pasture legume species in the last 
decade (Howieson et al., 2000). Several species that form this second generation are new to agriculture 
and hence their inoculants have not always accidentally been carried around the world. For these 
legumes, the inoculants arose following targeted acquisition activities and their pedigree can be clearly 
traced. It is likely that some of these new species will ultimately be sown across tens of millions of 
hectares. However, the wholesale value of their inoculant manufacture will be measured in the tens of 
thousands of dollars per annum, and thus royalties from these, were they to be imposed, would be 
almost insignificant. Royalties are not currently paid on commercially manufactured rhizobial 
inoculants in Australia and the strains are distributed to manufacturers on the basis of a non-exclusive 
licence. 
VAMs and ectomycorrhizae 
[40]Uptake of VAMs and ectomycorrhizae has been significant, particularly in subtropical and 
tropical agriculture in Asia, where aid programmes have demonstrated the benefits of inoculation in 
the nursery phase. As with RNB, there is not always a response to inoculation with mycorrhizae, 
because many soils already contain naturally effective strains. The challenge in utilizing VAMs more 
widely is to develop regional knowledge of where positive responses are likely to occur, and to 
develop strains of VAM that are adapted to both the soils and crops of interest. This has happened, for 
example, in rattan plantations in southern China, where selection of locally effective VAM strains has 
resulted in increased production of rattan. There appears to be a gradual increase in VAM application 
around the globe and this may spread to developed countries as P fertilizers become more expensive. 
Biocontrol agents, such as Metarhizium spp., B. subtilis and B. thuringiensis 
[41] Bacillus subtilis is naturally widespread globally, and was actually one of the first bacteria to 
have its genome fully sequenced. The uptake of this AMiGR has been predominantly in horticulture or 
intensive agriculture in developed countries. Of greater impact has been the related species B. 
thuringiensis, used as an insecticide in many countries since the 1950s. B. thuringiensis produces a 
range of crystal proteins with varying degrees of toxicity to coleopteran and lepidopteran insects. 
Genes isolated from B. thuringiensis have been incorporated into commercial plant genomes for 
protection against insect pests, the most notable of which is the cotton boll weevil. The Pasteur 
Institute has a broad collection of both genes and strains of B. thuringiensis available for research 
purposes. Several genes have been patented since 1980. Although target organisms evolve resistance 
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to Bt toxins, the combined application of chemicals and biopesticides such as B. thuringiensis is a seen 
as a desirable development in integrated pest management.  
[42] Metarhizium fungal spores can be produced in large-scale fermentors, but they can also be 
grown on sterilized rice in plastic bags for small-scale production. One limitation to widespread 
Metarhizium development is its sensitivity to temperature extremes; spore viability decreases as 
storage temperatures increase and virulence decreases at low temperatures. However, the broader 
application of Metarhizium to control cockroaches and white ants may increase its uptake. As for 
mycorrhizae, there has been a slow but steady uptake of AMiGRs as biopesticides since the 1950s, 
when the environmental implications of widespread chemical pesticides were first understood and 
publicized. 
China and India, and the use of PGPRs or YIBs 
[43] There has been historical acceptance of PGPRs in China, India and the former Soviet Union 
agriculture, with a research effort dating back some 50 years. The majority of these applications are of 
the diazotrophic microbes, in search of N accretion. It appears the use of PGPRs is static in these 
countries, neither declining nor becoming a mainstream activity. This influence is now spreading to 
South-East Asia, where co-inoculation of rice paddy fields with PGPR microbes (again predominantly 
diazotrophs) is gaining acceptance. There is certainly substantial research activity exploring the role of 
PGPR in rice growing in this region. Analysis of the published data on PGPR globally suggests that in 
more than 30 percent of reported applications of PGPR (generally associative N fixing Azotobacter, 
Azospirillum or Clostridium), a yield increase of 5 to 10 percent has been statistically demonstrated. It 
is difficult to gauge how much unreported experimentation with PGPRs is undertaken, and the range 
of the results of this work.  
[44] In developing countries, the focus of PGPR application is on phosphate solubilization, 
stimulation of root length and early root growth, disease suppression, and nodulation enhancement. 
There is little doubt that inoculation of agricultural plants with PGPR can elicit a measurable response 
in the plant for all these factors. It is more problematic to transfer this plant response into an actual 
increase in grain yield. 
VI. SURVEY TO ASSESS THE PHYSICAL NATURE OF CGIAR CENTRES HOLDINGS OF 
AMIGRS 
Current status  
[45] The Street (2000) review of AMiGR holdings in CGIAR Centres reported the breakdown of 
the microbial resources held at that time. A comparison is provided with the current situation in 
Table 1. 
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Table 1. Microbial resources held in CGIAR Centres in 2000 compared to 2005. 
Microbe or functional group Number in 2000† Number in 2005 
RNB 7780 6816 
Animal pathogens 1326 na 
Aquatic free-living N fixers 740 na 
Plant pathogens Undocumented >1000 
Entomopathogens Undocumented 125 
Mycorrhizae Undocumented >100 
Rumen microorganisms Undocumented na 
Non symbiotic beneficial microbes Na >600 
Total (documented) 9846 8641 
NOTES: † Data from 2000 derives from the review by Street (2000).na = data not available. 
 
[46] From information received for the CGIAR survey (December 2005), the situation has altered 
somewhat since the Street (2000) review. ICRISAT, for example, in addition to 715 RNB, now holds 
significant numbers of plant pathogenic fungi (>1000), as well as a range of PGPR microbes (306). 
Interestingly, ICRISAT has also accumulated a number of entomopathogens (120) in the last few 
years. This evolution reflects the changing global patterns of AMiGR research quite well (although 
global usage of AMiGR is still dominated by RNB). The number of PGPR microbes held by ICRISAT 
is also consistent with the historical acceptance of these forms of AMiGR in Indian agriculture. During 
the mid-1980s and until 1995, ICARDA had as many as five scientists working with AMiGRs, 
predominantly with RNB. There are now no scientists active in this area at ICARDA, and no projects 
are being serviced from the collection. However, the RNB germplasm has been lyophilized and an 
electronic database is kept updated. There is, however, activity in integrated pest management using 
biopesticides, so this represents a further indication of trends in AMiGR usage in the CGIAR system. 
The downturn in active research with RNB at ICARDA has coincided with an increase in the usage of 
RNB in west Asia and North Africa, where farmers are inoculating pulses with cultures of rhizobium 
strains selected and manufactured locally.  
[47] To provide a contrast to the response of the CGIAR Future Harvest Centres vis-à-vis other 
organizations, the questionnaire was also circulated within Australia. In Australia, holdings of RNB 
numbered approximately 7000, whilst there were collectively approximately 2500 plant pathogenic 
fungi, bacteria and viruses. The major institutions in Australia (e.g. CSIRO, State Departments of 
Agriculture, large universities) held collections of PGPR microbes and plant pathogens. The Grains 
Research and Development Corporation (GRDC) had implemented an AUD$ 10 million programme 
on Soil Biology (2003–2008), a large proportion of which is allocated to studying microbe-plant 
interactions. 
[48] It seems incongruous that many projects (seven at the time of the 2005 survey) were built 
around microbial germplasm repositories that were uniformly poorly resourced. In Australia, a current 
research emphasis on the development of novel perennial legumes would be severely constrained 
without immediate access to RNB germplasm. 
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PART 2 
VII. BASIC NEEDS AND CHALLENGES IN USING THESE AMIGRS IN THE GENERAL 
CONTEXT OF AGRICULTURAL DEVELOPMENT FOR THE COMING YEARS 
[49] The primary needs and challenges can be distilled down to four: 
• Discovering, preserving and cataloguing the available AMiGR biodiversity. 
• Accurately ascertaining the beneficial properties of any AMiGR. 
• Manufacturing, distributing and utilizing high quality AMiGR inoculants. 
• Ensuring equitable access to AMiGR and sharing benefits associated with their use . 
These challenges are discussed below. However, a substantial aid to the adoption of AMiGRs by 
developing countries would be the availability of a core set of AMiGRs (perhaps with representatives 
from each of the functional groups) that could satisfy the first two of the four requirements. 
Preserving biodiversity 
[50] CBD sets out principles of conservation and accesss and benefit sharing concerninggenetic 
resources. The application of the access and benefit sharing principles of the CBD is challenging in 
relation to AMiGR because microbes can easily transcend borders, as described earlier. CBD also 
suggests scientific experiments should be undertaken within the country of origin of the genetic 
resources, where possible. This is likely to be a difficult or impossible undertaking with AMiGRs 
because response to inoculation is likely to be species and environment specific.  
[51] In situ repositories are, of course, relatively inexpensive to maintain, but there are substantial 
sociological, legislative and community consultation procedures to work through to ensure they 
succeed. With continued development of arable land, are we certain that maximum genetic diversity 
can be protected in these repositories? Ex situ collections are the converse: with relatively low 
diversity and expensive to maintain. The very positive outcomes of the current ICARDA project in 
biodiversity conservation with in situ repositories should provide a framework for further development 
of such collections. AMiGRs for plants are inevitably preserved wherever in situ repositories are 
proclaimed, but they must be large to preserve microbes associated with animals. There is some debate 
as to how many in situ repositories are required to capture a wide sample of AMiGRs. While many of 
the AMiGRs are ubiquitous at the genus level, stress-tolerant strains or species of AMiGR usually 
evolve in the presence of that stress, and these situations may be local.  
[52] It is also pertinent here to discuss the loss of hosts for AMiGRs as an issue relative to loss of 
physical habitat of the AMiGRs. We can sometimes fall into the error of considering the AMiGRs in 
their habitat, but in isolation from their hosts. In reality, the loss of the host is more a threat to 
conservation of AMiGRs than the loss of diverse habitats, and this is more likely with animals than 
with plants. It is realistic to assume that whenever higher forms of life become extinct on this planet, 
then there is the strong likelihood that specific microbes associated with these lifeforms are also lost. 
[53] The biosecurity aspects of exchange of AMiGRs cannot be ignored. The key issues here are, 
from the recipients’ viewpoint, the potential loss of microbial biodiversity in situ following the 
application of an AMiGR to a new environment (i.e. competition for survival of microbes within that 
environment), the introduction of unwanted microbes, and the introduction of known pathogens. These 
are clearly matters of concern for sovereign governments, but are subjects of internal policy that 
should not be confused with the global exchange of AMiGRs. 
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Differentiating strains of AMiGRs 
[54] While species of AMiGR may be nearly ubiquitous, strains vary considerably. For example, 
strains of RNB that belong to a single species and that nodulate a single species of legume can differ 
greatly in their N fixation and ecological properties. Molecular techniques, usually based upon some 
form of PCR (such as PCR-RFLP [polymerase chain reaction - restriction fragment length 
polymorphism]) can reliably differentiate microbial species at the strain level, yet not all microbes are 
amenable to PCR. Techniques for reliably differentiating strains within the broad suite of AMiGRs 
(fungi, bacteria, archae, viruses, algae, etc.) would need to be developed. These techniques are almost 
certainly likely to be based upon molecular methods. 
Classifying microbes 
[55] As with the discussion on differentiating microbes, despite the wealth of molecular tools 
available, microbial taxonomy is in a state of rapid change as we learn more about lateral transfer of 
genes on mobile genetic elements. There is little consensus amongst microbiologists on how to 
reliably classify many microbes below the genus level, particularly the bacteria. Nomenclatural 
changes have the potential to unwittingly confuse the origins of some AMiGRs in collections. 
Handling AMiGRs 
[56]Microbes replicate very quickly and the conditions under which they are cultured can lead to 
genetic change (drift), mainly through loss of plasmids or DNA units bearing non-essential genes. 
Bacteria and fungi can be readily freeze dried or lyophilized in glass ampoules, and this should be the 
preferred mode of preservation. If ampoules are kept below 15°C, the microbes commonly have a life 
span of over 50 years. However, not all microbes can be lyophilized or stored at -80°C. The 
microalgae are one such class of AMiGR that must be routinely subcultured, which is expensive and 
unreliable. So the optimal methods for handling some types of microbes for long-term storage needs 
further research.  
Code of conduct 
[57] With MOSAICS [Microorganisms Sustainable use and Access management Integrated 
Conveyance System – an EU initiative], a voluntary and guiding code of conduct already exists to 
assist suppliers and receivers of materials ensure that they are in compliance with the basic tenets of 
the CBD, namely that materials are accessed subject to prior informed consent (PIC) and on mutually 
agreed terms. This covers access to and circulation of MGRs, a pathway that tracks utilization and 
potential commercial benefits arising from exploitation of MGRs. This could be adopted for AMiGRs. 
MOSAICS is premised on the notion that suppliers and access seekers will negotiate new terms and 
conditions for each case. One possibly very useful value-added approach would be to develop a 
harmonized, pre-agreed set of terms and conditions that could be used for exchanges between a wide 
range of parties for specified purposes, such as research, conservation, etc. Such a harmonized 
approach would usefully complement the development of an internationally publicly available core set 
of AMiGRs, as discussed elsewhere. 
Institutional continuity 
[58] The world AMiGR collections appear to be associated with individuals rather than institutions, 
and thus when the individual relinquishes their position, the germplasm collection suffers. This seems 
to be the case for most CGIAR collections, which are ‘working collections’ rather than genebanks per 
se. The contrast here might be made with herbaria, seed banks or some microbial collections, such as 
those at USDA-ARS and Ghent (Laboratorium voor Microbiologie, Universiteit Ghent) where there is 
substantial funding for long-term curatorial purposes. Of significance is that a well-maintained culture 
collection is the product of many work-hours of collection, propagation, preservation, 
experimentation, authentication and documentation. It represents intellectual property that should not 
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be summarily dispensed with, and successional planning through the appointment of a curatorial 
position is the best way to achieve security. 
Trends in amalgamating AMiGR collections 
[59] In both the USA and Australia, the trend over the last two decades has been towards 
amalgamation of collections, particularly for RNB. With the withdrawal of CSIRO from rhizobiology, 
the Australian CSIRO collections (prefix CB (Brisbane), and CC (Canberra)) have been amalgamated 
into the WSM (curator Howieson, Perth), SARDI (curator Ballard, Adelaide) and US (curator 
Kennedy, Sydney) genebanks. However, only the lyophilized cultures were transferred (some 1000 
cultures), with those held on agar slopes being destroyed. The Sydney US genebank is considered to 
be vulnerable, with the imminent retirement of Professor Ivan Kennedy. This situation reflects the 
generally poor long-term planning in relation to germplasm of AMiGR at the global level, even where 
the value of these microbes is acknowledged.  
Recognizing and attaching value to AMiGRs 
[60] In many traditional disciplines of biology, the value or role of microbes is not (transparently) 
recognized. For example, in the International Union of Forest Research Organizations (IUFRO) there 
is the IURFO Root Physiology and Symbiosis Unit. This unit has no public policy on the preservation 
of forest microbial genetic resources. It seems that most collections of forest microbes are privately 
owned and held in universities. 
[61] However, in the USA, the USDA ARS has assumed responsibility for the majority of RNB 
collections held on the North American continent (curator Peter van Berkum). This raises the 
possibility of a model for AMiGR collections, with one repository per continent being nominated as 
the key core collection.  
[62] A more detailed look at the USDA Agricultural Research Service (ARS) system in relation to 
AMiGR is provided below. 
USDA ARS NATIONAL MICROBIAL GERMPLASM PROGRAM  
[63] The goal of this programme is to ensure that the genetic diversity of agriculturally important 
microorganisms is maintained to enhance and increase agricultural efficiency and profitability. The 
programme will collect, authenticate and characterize potentially useful microbial germplasm; 
preserve microbial genetic diversity; and facilitate distribution and utilization of microbial germplasm 
for research and industry [Author’s note: this is in the context of benefit to the USA as presented in the 
US Farm Bill outlined in Appendix 3]. 
[64] ARS in fact maintains several microbial germplasm collections, including: 
• ARS Culture collection 
• ARS Collection of Entomopathogenic Fungal Cultures (ARSEF) 
• ARS National Rhizobium Genetic Resource Center 
• ARS National Fungus Collections 
The ARS National Rhizobium Genetic Resource Center has allocated funding of US$ 140 000 per 
annum in addition to the salary of its curator. 
[65] Some aspects of the management and policies of these collections are relevant to this review: 
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 Identifying and acknowledging ARSEF strains in publications 
‘We ask that all publications using or referring to strains obtained from ARSEF acknowledge 
the ARSEF culture collection and state the ARSEF accession numbers of these strains. We 
would greatly appreciate receiving reprints of all past, current, and future publications 
involving ARSEF strains.’ 
Accession numbers of strains from commercial culture collections, such as the American Type Culture 
Collection (ATCC), Centralbureau voor Schimmelcultures (CBS), CAB International Mycological 
Institute (IMI), and the University of Alberta Microfungus Collection (UAMH), are listed in this 
catalogue only for the sake of providing complete information. Cultures received from ARSEF should 
be referred to by their ARSEF numbers only. Citation of cultures obtained from ARSEF by any 
corresponding ATCC, CBS, IMI or UAMH accession numbers they may also have is a violation of 
trademark laws; persons doing so are subject to prosecution. 
 Updated, special, and electronic catalogues 
Periodic updates of the general and special ARSEF catalogues and the update to the printed 1992 
catalogue will be mounted on the Web page. Printed copies of the 1992 catalogue of ARSEF isolates 
(covering isolates up through 3736) are available without cost upon request to the curator. 
Complimentary copies of the ARSEF database and the customized application used to manage it can 
be obtained upon consultation with the curator of the ARSEF collection. It was anticipated that a fully 
interactive, searchable version of ARSEF culture accession data would be made available on the Web 
site in 2004. 
 Depositing and exchanging cultures 
The ARSEF culture collection encourages deposition of entomopathogenic fungal cultures—
particularly strains used in published studies—as well as of voucher and reference specimens to its 
herbarium. Depositors may reserve the right to limit redistribution of any culture deposited with 
ARSEF for specified periods upon consultation with the curator. Depositors can receive subcultures of 
their own depositions at any time; these cultures do not affect any allowances for free cultures. 
Exchanges of cultures between ARSEF and other research or general collections of fungal cultures are 
encouraged and are not subject to numerical limits. 
[66] Prior to shipping cultures from countries outside the United States, contact the Curator to 
obtain the appropriate needed importation permit from the U.S. Department of Agriculture, Animal 
and Plant Health Inspection Services, Plant Protection and Quarantine. When sending cultures and/or 
specimens to ARSEF, it is very important to include as much of the following information as possible: 
• Scientific name (and taxonomic authority) of the fungus.  
• Common and scientific name (with taxonomic authority) of the host.  
• Order and family of the host. [This is essential information!]  
• Date and site of collection.  
• Name of collector.  
• Date and name of isolator.  
• Any collection, accession, or other identifier number(s) applied by the collector or sender.  
• Medium on which a culture is sent.  
• Any special requirements or conditions for growth (such as medium, temperature, pH).  
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 Diagnostic Services for Cultures and Specimens 
Specimens and cultures of unidentified fungi from invertebrates can be submitted to ARSEF for 
diagnosis. This service is an important function of the ARS Collections of Entomopathogenic Fungi 
and is provided without charge. Identifications and information about the disposition of specimens will 
be mailed to the sender. 
 Release of ARSEF Cultures from Containment or Quarantine 
Neither the curator nor any employee of ARSEF or of the Plant Protection Research Unit is entitled to 
authorize the release of any culture it provides from laboratory containment or quarantine in the 
United States or elsewhere. Recipients of ARSEF cultures are responsible for obtaining all appropriate 
and necessary permissions from or for providing official notifications to State and Federal regulatory 
agencies. 
The pragmatic value of a core set of authenticated AMiGRs 
[67] This document hypothesises that a core set of ‘authenticated’ AMiGR might be developed by 
scientists and institutions who have historically collaborated in exchange of microbial germplasm. A 
core set would be different from a type set: the latter providing a taxonomic basis, the former 
providing a proven phenotype. The benefits of a core set would be two-fold. Firstly, it has been 
identified that the development of AMiGRs is hindered by the need for researchers to devote 
substantial time to procurement of microbes, followed by purification (if the organism is not from a 
reliable source), identification, laboratory or glasshouse evaluation, and finally in situ 
experimentation. The steps between procurement and in situ experimentation are considered as 
authentication. The second advantage is that developing countries (from which many AMiGR have 
been sourced) would perhaps be great beneficiaries of such a scheme, as the authentication steps can 
be difficult. As an example, if a research group were interested in developing a plant growth 
promoting organism based on the enzyme ACC deaminase, there may be several work-years required 
for isolation, purification, development of the bioassay for production of the enzyme, then selection of 
isolates for evaluation in situ. This same process has been undertaken in many laboratories over the 
last 20 years, and by now there should be available a set of strains, probably representing many 
species, that are well characterized for this enzyme. Selections from among these would represent a 
core set of ACC deaminase strains from which new projects might be developed. They could be 
thought of as ‘control’ strains for comparison with new isolates, or possible strains for commercial 
development in their own right. The concept of a core set parallels the ‘type’ strains available for 
serious diseases, or cancerous cell lines, which are widely distributed in medical research laboratories. 
It differs from current taxonomic ‘Type Strains’ in culture collections in the sense that the phenotypes 
of the core set of microbes would be substantially well researched. For example, the taxonomic Type 
Strain for Sinorhizobium meliloti is Sm1021. Although much is known about Sm1021 genetically, it is 
poor at nitrogen fixation when in association with many species of its host genus Medicago. Sm1021 
would thus not be very useful as a core strain for evaluation in agricultural settings.  
[68] So, how might this core set concept work in practice? The concept might initially be floated at 
the major international microbiology conferences. If there was general enthusiasm for the concept at 
the individual level, which was then supported at the institutional level, there would follow 
development of a working party to assess which AMiGR groups might be suitable for inclusion in the 
core set. Obvious candidates are the RNBs, PGPRs, pathogens, pathogen suppressors and probably 
others from the major functional groups 1–8 in Figure 1. An ensuing Web-based activitymight then be 
suitable for the process of deciding which AMiGR groups, and then which individual species and 
strains, might be accepted as the core set for each group. The strains finally accepted into the core 
group would be based upon agreed standard levels of authentication and, importantly, in situ 
performance from a number of valid tests. 
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[69] The major costs in developing and then servicing a core set of AMiGR are difficult to predict. 
The development phase might be potentiated by direct donations of strains from individuals or 
institutions. The costs of servicing the core set would be determined to a substantial extent by the 
demand. An estimate of the cost might be gained from enquiry through the USDA in relation to their 
RNB, or the Pasteur Institute for their Bacillus thuringiensis collection. 
[70] Suitable partners in developing a core set of AMiGRs in the initial phase would be the CGIAR 
genebanks and public institutions such as the USDA, which have demonstrated a willingness to hold 
publicly available materials and supply them internationally. If the concept were favourably received 
(and there was appropriate recognition for acceptance of an organism into a core set, such as journal 
publication), it is possible that donations to the core set might rapidly gather momentum. 
[71] A further consideration concerns how much of the usefulresources currently held by 
organizations could actually be globally, publicly distributed. This is a question that would require 
extensive review of each accession’s legal status with reference international laws, national laws, 
intellectual property ownership, and the conditions under which those materials were supplied (and by 
whom) to the organizations concerned. 
VIII. OBSTACLES FOUND IN USING AMIGRS, WITH EMPHASIS ON DEVELOPING 
COUNTRIES  
Accurately ascertaining the beneficial properties of any AMiGR and demonstrating bona fide 
responses to inoculation of AMiGR 
[72] The data for AMiGR response, apart from RNB and mycorrhiza, is seldom convincing. For 
RNB, the USDA NifTAL programme, and its follow up, the Worldwide Rhizobial Ecology Network, 
noted that where rhizobial populations of compatible strains were less than 10 per gram of soil, 
93 percent of experiments produced yield increases in excess of 140 percent. However, where soil 
numbers were higher, 10 to 100 per gram of soil, the response dropped dramatically, to 68 percent 
frequency and 8 percent magnitude (Herridge, 2005). Determining the need to inoculate and then the 
response for other AMiGRs represents a substantial barrier to their scientific credibility and their 
adoption. As noted previously, for associative diazotrophes the frequency of response to inoculation 
drops to around 30 percent of published reports, but the magnitude to an alarmingly low 10 to 
30 percent. These responses are difficult to accurately measure. In China, India and the former USSR, 
the relatively widespread use of AMiGRs seems to be more a cultural phenomenon than scientifically 
based. Perhaps there is merit in accepting that responses to AMiGRs will rarely, if ever, be 
comparable with those from RNB. 
Decision-making in relation to the opportunities or benefits arising from application of AMiGRs 
[73] The information explosion has delivered a multitude of reports relating to successes or failures 
with AMiGRs. Access to these reports is becoming more efficient, with on-line journals, although the 
information transfer to developing countries is certainly slower than for developed countries. 
Notwithstanding this, most reviewers acknowledge that responses to inoculation with AMiGRs are site 
and species specific. Thus, a major obstacle in developing countries to uptake of AMiGRs is in 
assessing whether there is likely to be local benefit from them. Although decision-making of this kind 
is not simple, Figures 3 to 5 illustrate a model developed for legumes and inoculation with RNB that 
could be adapted by regional scientists for application to a broader range of AMiGRs. 
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Figure 3. A flow chart illustrating the range of decisions required prior to initiating a legume or 
rhizobial selection programme. 
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Figure 4. Component B. The possible outcomes of a preliminary inoculation experiment to determine 
if a legume requires inoculation in a particular soil. The experiment has three legume treatments-
uninoculated, inoculated with a “best bet” strain and N-fertilized.The ensuing research requirements 
are represented in Component C (see Figure 5). 
Notes: trt(s) = treatment(s). uninoc = uninoculated. 
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Figure 5. Component C. Research strategies for increasing N2 fixation (after Sessitsch et al., 2002).  
[74] As previously mentioned, the availability of a core set of AMiGR with which to experiment 
within the boundaries of this decision-making model would perhaps greatly benefit the uptake of 
AMiGRs in developing countries. A core set of AMiGRs could readily be developed by scientists who 
have collaborated in microbial germplasm exchange and evaluation programmes with the CGIAR 
centres. 
MANUFACTURING, DISTRIBUTING AND UTILIZING MICROBES 
[75] After recognizing the value of AMiGRs and demonstrating responses to inoculation with 
them, the next step in utilizing AMiGRs is to manufacture them in sufficient quantity and with 
sufficient quality to ensure their adoption. In developed countries, the factors militating against 
adoption include the ease of applying alternatives to AMiGRs (chemicals, fertilizers). In developing 
countries, the problems are more microbiological. 
Problems with manufacturing technologies in developing countries 
[76] If the decision is made to manufacture AMiGR, then bacterial or fungal inoculants need to be 
produced in a fermentation process, usually under conditions of controlled sterility. The key 
challenges in manufacture of AMiGRs include: 
• ensuring that the right organism is cultured during the fermentation step, i.e. that the inoculant is 
the desired organism and the growth phase is uncontaminated; and 
• ensuring the fermentation is carried to completion (i.e. to achieve high numbers) and harvested 
without injury to the microbe. 
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[77] After fermentation, the microbes must be stored in a ‘carrier’ material until applied to seed, 
plants or soil. Carriers include: 
• soils, such as ground peat, coal or lignite; 
• plant material, such as charcoal, composted straw, bagasse, rice husks or coir dust; 
• inert materials, such as vermiculite, perlite, bentonite, clay, phosphate rock, talc or alginate; or 
• combinations of the above, such as a mixture of soil, clay and compost. 
[78] The type of carrier developed usually depends on the availability of materials in reasonable 
proximity to the fermentation facilities. The key challenges in carrier selection are: 
• ensuring the carrier protects the organism for a period sufficient to utilize the inoculant; and  
• ensuring the carrier maintains high numbers of the inoculant capable of engaging with the target 
plant, insect or animal. 
[79] Low rates of usage of AMiGR in many countries may reflect problems of supply or regional 
access to AMiGR, rather than reflect the actual intent of the farmer, who might be amenable to the 
purchase of a bona fide inoculant. Thus, lack of a reliable infrastructure for AMiGR production may 
restrict adoption, even if the organisms have proven efficacy.  
Documentation and databases to aid transfer and to track acquisition and usage 
[80] As with any scientific pursuit, it is essential that records be kept of experimental outcomes. 
However, because the nature of AMiGR research is long term, it is even more essential that good 
databases are developed to record the information generated with any series of experiments with 
AMiGR. This is essential where AMiGR repositories mature to become associated with institutions 
rather than individuals. In the case of the CGIAR system, the use of electronic databases to record and 
track the use of AMiGR acquisition and outcomes of experiments with them is strongly recommended. 
IX. INFORMAL (NON-LEGALIZED) CUSTOMS DEVELOPED FOR THE ACQUISITION, 
DISTRIBUTION OR EXCHANGES OF AMIGRS  
Record-keeping 
[81] Many curators historically recorded the distribution of their cultures, more as a thorough 
record-keeping exercise than as a legal requirement. There was generally an understanding between 
scientists that the culture would be referred to with its initial accession number in any publication in an 
international forum and this provided some tracing of cultures. This has changed somewhat over the 
last 15 years. There currently exists relatively substantial record-keeping relating to acquisition and 
exchange of at least some AMiGRs. In the case of RNB, acquisition activities by institutions are now 
only undertaken with the full knowledge and cooperation of the country of origin. Material from 
collecting missions is then usually shared between collaborators at the point of collection, or after 
isolation and preservation has been achieved. The acquisition activity is usually preceded by written 
declarations of intent that describe the intended scope of the activities. This scenario differs 
significantly from that which existed pre-1994, where acquisition activities were frequently 
undertaken without the written consent of legally constituted authorities in the country of origin and 
following established access and benefit sharing laws, since relevant international standards and 
national laws generally did not exist. 
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X. TOWARDS CODIFICATION OF ACTIVITIES: DIRECTIONS AND ORGANIZATION 
TYPES GENERALLY INVOLVED  
MTAs and MOUs 
[82] There is now a general requirement for the preparation and signing of Memoranda that deal 
exclusively with the acquisition, exchange, research and future commercialization of any AMiGR. 
These documents are usually inter-institutional, rather than inter-governmental. In the case of the 
distribution of cultures from germplasm resource centres, requests for cultures may now often be met 
with Material Transfer Agreements (MTAs) that specify, amongst other things, that negotiation is 
required with the ‘owners’ of the material before commercial activities are to be undertaken. Usually, 
AMiGRs cannot be forwarded to a third party. An example of a current MTA is appended (Appendix 
3). The exchange of AMiGRs has thus moved substantially towards an official activity, with record 
keeping and commitments by both parties.  
Re-selection  
[83] The issue of re-selection is significant. Microbes may divide and double their number within 
30 minutes, and the offspring may be slightly different to the parents, depending upon how they are 
cultured. For example, at a mutation rate of 1 in 100 million, which is not high, any plate of bacteria is 
likely to have up to ten colonies that differ from the parents. It is, for example, a very basic step in 
microbiology to select for natural antibiotic resistance mutants. This rapid rate of change clearly has 
the potential to make claims for intellectual property ownership a significant challenge.  
XI. POSSIBLE DIFFERENCES AMONG CODIFICATIONS APPLICABLE TO AMIGRS 
AND TO MGRS 
AMiGRs differ from MGRs 
[84] AMiGRs are generally delivered live to their target (soil, plant, insect, animal) whilst MGRs 
transform a process and then are eliminated. This is a major difference between AMiGRs and MGRs 
that affects their codification. For almost all AMiGRs, the organism itself is manufactured then 
utilized in a live state. Thus, to elicit the required response the microbe is distributed by inoculation of 
or placed in the vicinity of the target organism, using live cells, or fruiting bodies that should develop 
into live cultures. This contrasts with the utilization of MGRs, the vast majority of which act as 
microbial catalysts in a production sequence where the end product contains no live cells of the 
microbial agent. For example, yeasts ferment grape juice into wine or champagne and then die, with 
no live cells usually present in the final product. Similarly, whilst Agrobacterium might produce 
transformed cells, the bacteria itself is ultimately removed from the target organelle (although there 
are exceptions, such as the lactobacillus used in yoghurt manufacture). Because MGRs are generally 
utilized within a contained process, there has followed the “ownership and protection” of MGRs. 
Breweries have their favourite yeasts, which they closely guard, and laboratories store their unique 
transformation vehicles. The same protection is not available to AMiGRs, because once they are 
released into the environment, it is generally a simple matter to recover the organism.  
XII. IMPACTS OF NATIONAL QUARANTINE LAWS  
Labelling 
[85] The primary requirements for import and export of agricultural microbes relate to labelling, in 
particular in relation to any potential hazardous substance. These must be disclosed and penalties for 
not doing so may be applied to both the exporting and importing agent. For animal pathogens, in 
particular those that are the subject of global quarantine efforts, access to microbial germplasm 
remains as strictly controlled as that of animal shipment. Aside from this, there is very little 
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monitoring of the exchange of agricultural microbes in most countries, and the unintentional trade of 
microbes across the globe continues to increase in association with shipments of grain, animals and 
fodder. However, those countries with strict quarantine laws are becoming increasingly stringent about 
the importation of microbes. Thus AQIS, the Australian Quarantine Inspection Service, prohibits the 
import of AMiGRs without special permits, and this is having a substantial impact upon the 
development of AMiGRs in that country.  
XIII. TRENDS IN PATENTING OF UNMODIFIED AND MODIFIED MICROBIALS  
AMiGRs and intellectual property 
[86] In any handful of soil, from most places on the planet, there is likely to be in excess of 100 
populations of different microbes, some of which will exceed 1 billion individuals in that handful. 
From this handful of soil there is the potential to develop one or more AMiGR inoculants. The 
widespread availability or natural distribution of microbes has several implications. The first is that it 
is almost impossible to demonstrate the origins of an AMiGR unless that AMiGR is highly specific. 
An example of a highly specific AMiGR might be the bacteria from which DNA polymerase for many 
PCR reactions originates, i.e. from thermal pools, which are a relatively restricted environment. Other 
than these rare examples, AMiGRs from common environments are ubiquitous. The intellectual 
property in their development, therefore, is associated with proving theirutility/industrial application 
rather than discovering the organism per se. This in turn means that it might be difficult to protect the 
intellectual property associated with many AMiGRs. For example, it is public knowledge that RNB fix 
nitrogen, RNB are ubiquitous, and therefore it is a relatively simple matter to isolate RNB from 
legumes to develop inoculants that simply can not be protected by intellectual property (IP) rights 
legislation. Whilst procaryotic AMiGRs can be patented, this is not a common practice. 
[87] As noted earlier, microbes routinely double their number within 30 minutes when grown under 
favourable conditions. This provides the opportunity to generate inoculants within days, and the 
implications of this are that a competent manufacturer may develop a commercial-quality inoculant 
from a starter culture within a very short time-frame. This makes AMiGRs uniquely attractive as a 
small business opportunity in developing countries where local fermentation expertise is available. 
This is why many aid programmes, such as USAid (through NifTal), have focused upon AMiGRs. 
There is, however, a down side to rapid reproduction. The first consideration is that with the rapid rate 
of reproduction comes a potential for rapid mutation, or change. If the altered genotype is favoured in 
the production environment, the new genotype will soon dominate the population (this could be 
considered evolution). This, in turn, has implications: firstly, if the change is not beneficial then the 
inoculant may not be efficacious (and hence AMiGR production requires stringent quality control), 
and, secondly, if the original AMiGR was protected by patent, it is unlikely that the patent would 
apply to the evolved genotype. A similar scenario can occur for microbes delivered to soil. There is 
substantial acceptance and donation of DNA between even distantly related organisms, which leads to 
relatively rapid evolution or change. A major implication of rapid reproduction, then, is that it brings 
with it difficulties in intellectual property protection associated with the difficulties in proving identity.  
Trends in patenting 
[88] It seems commercial manufacture of AMiGRs is accompanied by patent applications, more so 
than through the activities of the genebank curators themselves. Executives of Becker Underwood in 
Australia were contacted on 10 August 2005. Becker Underwood are a major global manufacturer of 
AMiGRs. They had patented the use of microorganisms as biocontrol agents (although not RNB) in 
the USA and in Australia. These patented AMiGRs are not genetically modified and are occur 
naturally in the environment. The AMiGRs under patent have been selected in research programmes 
for specific purposes (e.g. Metarizium as an inseticide). This suggests that some patent laws now 
recognize and offer protection forinvestment in scientific researchof microbes that have been isolated 
from the environment and used in specific ways.  
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[89] A second manufacturer of AMiGRs in Australia, ALOSCA Pty Ltd were contacted on 14 
August 2005. At that time, they had patented their delivery technology rather than specific microbes. 
[90] New strains developed through scientific research and then made available for commerce are 
provided to Australian manufacturers free of charge under the conditions of a non-exclusive licensing 
arrangement, but only to those manufacturers who are participants in the Australian quality control 
programme (ALIRU). 
Procaryotes protectable as intellectual property 
[91] Although this document presents some pragmatic challenges associated with patenting of 
AMiGRs, the case of Diamond v Chakrabarty in the US Supreme Court has shown prokaryotes may 
be patent protectable under law in the USA, a decision that remains unchallenged today. The most 
current issue of Bergey’s Manual (2005) has a paper by R.D. Meredith that examined the 1998 
position on protecting IP in prokaryotes. In summary, at that time, prokaryotes were protectable if they 
were considered new inventions, of practical value and not simple variants of an entity already 
anticipated in the public domain. It was noted by Meredith that the law is evolving. The case was 
decided in favour of the applicant (5-4), which, in the opinion of the author, is indicative of a 
challengeable position. In the sense of AMiGR, it would be difficult in many cases to establish that a 
similar entity was not anticipated in the public domain. Procaryotes that are deliberately genetically 
altered to deliver a unique product (e.g. insulin) would be an obvious exception.  
XIV. CONCLUSIONS 
[92] Drawing on the preceding sections of this paper by Dr Howieson, the Genetic Resources 
Policy Committee of the CGIAR seeks to highlight a number of potentially important issues: 
1. It is possible to develop a working definition of agricultural microbial genetic resources 
(AMiGR) on the basis of the function for which those resources are used, i.e. the fact that that 
they assist in the production of plants or animals, either directly or indirectly, in agricultural 
settings.  
2. Because of a combination of factors concerning microbes used in agriculture—for example, 
their deployment in open environments; their extremely fast rates of reproduction and 
variation; their small size and portability; and historical patterns of use and distribution—it is 
difficult, and often impossible, to subject them to legal forms of control or appropriation. A 
large number of patents, however, have been granted in some countries over microbes as well 
as genes and proteins derived therefrom.  
3. AMiGR are potentially extremely important for the sustainable improvement of productivity 
in developing countries, subject to biosafety considerations. However, they are as yet not 
widely exploited in a systematic manner in developing countries.  
4. One possible way to increase the availability to, and use of AMiGRs by, developing countries 
would be to develop a ‘virtual’ core collection of screened materials currently held by public 
organizations around the world that wanted to participate. A critical aspect of this enterprise 
would be to agree upon harmonized terms and conditions for the distribution of those 
materials, in conformity with international law. The process for considering the establishment 
of such a base collection and the terms and conditions for its use would need to be highly 
participatory, with costs, legal status, partners, administrative responsibilities and other issues 
identified and exhaustively considered.  
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APPENDIX 1 
A BRIEF DESCRIPTION OF SOME COMMON AMIGRS WITHIN THEIR ASSIGNED 
FUNCTIONAL GROUPS 
PLANT SYMBIONTS 
[A1.1] Plant symbionts are microbes whose actions directly improve plant growth, usually by supply 
of otherwise limiting nutrients such as nitrogen or phosphorus. Root nodulating bacteria (RNB) are the 
best-researched example of microsymbionts for plant growth, reducing inert di-nitrogen gas in the 
atmosphere to a form that legumes can metabolize, usually amino acids. There are six main genera of 
RNB, including the phyllosphere microorganism Azorhizobium that forms stem nodules on Sesbania. 
The stem nodules and their microbial occupants may also be photosynthetic. Actinorhizae are fungi 
that form Frankia-type nodules on non-legumes, within which N fixation also takes place. The 
microbe genus Frankia can now be cultured on complex media and hence Frankia spp. are suitable as 
AMiGRs and can be applied to at least seven families of non-leguminous plants, the most utilized 
plants being in the genera Casuarina and Alnus.  
[A1.2] The Cyanobacteria may also be listed under this heading, as they have the capacity to form 
symbiotic associations with eukaryotes and to fix atmospheric N. Nostoc is the most exploited genus 
of this group. 
[A1.3] Mycorrhizae are root-fungus associations that effectively extend the rooting-zone of plants. 
There are six major types of mycorrhizae. The endomycorrhizae are of particular interest, although 
they can not be grown without the plant and therefore remain difficult in an AMiGR context. 
RUMEN ORGANISMS 
[A1.4] The rumen of methane-producing animals such as sheep and cattle contains a large and diverse 
microbial community of anaerobic fungi, such as Neocallimastix, prokaryotes, ciliates and protozoans. 
There may be as many as 1 × 1012 organisms per millilitre of rumen fluid. These microbes act together 
to break down the cellulosic plant components, mainly through the action of anaerobic prokaryotes 
and protozoans. Other bacteria then ferment carbohydrates to volatile fatty acids, carbon dioxide and 
methane, which the Archaea produce from acetate, carbon dioxide and hydrogen gas. Having 
performed their tasks, the rumen microorganisms are digested in the adjacent stomachs to yield amino 
acids and sugars for ruminant metabolism. 
ASSOCIATIVE ORGANISMS  
[A1.5] Associative organisms are organisms that elicit or potentiate a positive reaction or effect when 
in intimate proximity with a plant or animal. The best known are Plant Growth Promoting Rhizosphere 
(PGPR) organisms and Yield Increasing Bacteria (YIB) 
[A1.6] The most common of these are the diazotrophs, including Azotobacter, Azospirillum, 
Acetobacter, Azoarcus, Clostridium, Enterobacteriaceae and Herbaspirillum, as well as the facultative 
nodule bacteria Burkholderia, Rhizobium and Azorhizobium, which have been shown to have 
additional associative effects in cereals. Most of these associative organisms may supply small 
amounts of N to crop plants, which may be useful in N-deficient systems, and this can be measured 
using the %ndfa natural abundance technique. Azospirillum has been shown to increase yield by 5 to 
30 percent in about 70 percent of reported trials. However, they may also have a range of other 
functions related to hormone, siderophore or chelate production, or nutrient solubilization. Another 
class of microbes that is becoming well-researched in contemporary laboratories is the ACC group. 
This group deaminates 1-amino cyclopropane -1-carboxylate, which is a precursor to ethylene. 
Ethylene may be injurious to plants grown under stress. Avoidance of exposure to ethylene can 
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increase plant growth. The most studied ACC organism is Pseudomonas putida. There are accepted 
methodologies to assay for these functions. 
BIO-CONTROL AGENTS (PATHOGENS OF WEEDS, FUNGI, INSECTS OR 
NEMATODES) 
[A1.7] The use of microbes to control pests through parasitism, pathogenicity or competition is 
considered an environmentally sound use of AMiGRs, with significant potential in agriculture. A well 
documented bioinsecticide is Bacillus thuringiensis, which produces toxin crystals effective in 
controlling coleopteran and lepidopteran insects. Bt has been utilized for over 20 years in cotton crops 
to control the Boll Weevil, and Bt toxin genes have been transferred into both plants and bacteria for 
similar purposes. A large collection of Bt toxin genes are maintained by the Pasteur Institute in Paris. 
Other examples of the current application of AMiGRs as biocontrol agents include Bacillus subtilis as 
a pathogen of fungi; Agrobacterium cured of the Ti plasmid as a competitor against Crown gall-
inducing Agrobacterium; Pseudomonads as weed control agents; Metarhizium as a control agent for 
locusts and grasshoppers; and the twist fungus as an inhibitor of nematode and Corynebacterium 
induced toxicity of annual ryegrass. The nuclear polyhedrosis viruses (NPVs) have proven effective 
against lucerne and celery loopers, and could be employed in genetic modification studies to control 
insect pests of agricultural plants. 
FERMENTATION OF FOODS AND BEVERAGES 
[A1.8] Yeasts are used in bread, beer and wine manufacture; Streptococcus and Lactococcus in dairy 
products such as cheese and yoghurt, as well as in nisin production, which may be used as an anti-
spoilage treatment; Penicillium camamberti is used in the later stages of camembert production; 
Acetobacter in wine-vinegar production; Lactobacillus in production of fermented meats; Aspergillus 
and Rhizopus in soy fermentation. Many of these genera have a role elsewhere in Agriculture. 
MASS CULTURE OF MICROALGAE AS A SOURCE OF PIGMENTS OR ANTIOXIDANTS, 
OR AS A FEED BASE FOR HIGHER ORGANISMS 
[A1.9] Mass culture of microalgae is routinely undertaken in aquaculture facilities for production of 
feed-base to provide bulk for fish, cattle, pig or poultry feed. Examples include Chlorella spp., 
Isochrysis spp. and Pavlova spp. Microalgae may also be grown in high volume culture for fine 
chemical production, such as phycocyanin from the Cyanobacterium Spirulina; beta-carotene from 
Dunaliella salina; and astaxanthan from Haematococcus pluvialis. These are global aquacultural 
industrial processes. Cyanobacteria have a key role in rice production. 
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APPENDIX 2 
AN EXTRACT FROM THE CURRENT US FARMBILL 
 
US Farmbill 
Appendix I 
104 STAT.3744 
Public Law 101-624-Nov. 28, 1990 
Title XVI 
Subtitle C--National Genetic Resources Program  
7 USC 5841.  
SEC. 1632. Establishment, Purpose, and Functions of the National Genetic Resources Program  
(a) IN GENERAL.--The Secretary of Agriculture shall provide for a National Genetic 
Resources Program. 
(b)  PURPOSE.--The program is established for the purpose of maintaining and enhancing a 
program providing for the collection, preservation, and dissemination of genetic material of 
importance to American food and agriculture production.  
(c)  ADMINISTRATION.--The program shall be administered by the Secretary through the 
Agricultural Research Service.  
(d)  FUNCTIONS.--The Secretary, acting through the program, shall--  
(1) provide for the collection, classification, preservation, and dissemination of genetic 
material of importance to the food and agriculture sectors of the United States;  
(2) conduct research on the genetic materials collected and on methods for storage and 
preservation of those materials;  
(3) coordinate the activities of the program with similar activities occurring domestically;  
(4) unless otherwise prohibited by law, have the right to make available upon request, 
without charge and without regard to the country from which such request originates, the 
genetic material which the program assembles;  
(5) expand the types of genetic resources included in the program to develop a 
comprehensive genetic resources program which includes plants (including silvicultural 
species), animal, aquatic, insect, microbiological, and other types of genetic resources of 
importance to food and agriculture, as resources permit; and  
(6) engage in such other activities as the Secretary determines appropriate and as the 
resources of the program permit.  
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APPENDIX 3 
AN EXAMPLE OF AN MATERIAL TRANSFER AGREEMENT (MTA) THAT RELATES 
TO MICROBES 
The CHIEF EXECUTIVE OFFICER OF THE INSTITUTION, a body corporate under the xxxxx 
Act 1988 (COUNTRY) having its offices at xxxxxxxxxxxxx and the Recipient requires the 
following Details set out in Schedules 1, 2 and 3 to be provided to allow for the exchange of 
Genetic Material (hereinafter called ‘Material’) under the Terms and Conditions of this Agreement. 
 
 Item SCHEDULE 1: Details 
1 Description of Material to be 
transferred 
(If further details are attached please tick the 
box below and complete Schedule 2) 
  Further Details Provided in 
Schedule 2 
Common Name: 
Species: 
Identifying Codes: 
Other attributes: 
2 Quantity and form of Material  Quantity: 
M
AT
ER
IA
L 
3 Nominated Delivery Date Date: 
 
4 Recipient’s 
Details 
Organization: 
Delivery Address: 
Contact Name 
 
Purpose 1 
 As parental material for crossing with genetic 
material only 
Purpose 2 
 As reselection material only 
Purpose 3 
 As testing and evaluation material only 
Purpose 4 
 As genetic manipulation material only 
Purpose 5 
 
5 Purposes for 
which the 
Recipient can 
use the Material  
(Please place an “X” 
in only one of the 
boxes on right, and 
complete Schedule 
3 if Purpose 5 is 
chosen)   
For any Purpose above where special conditions 
apply, a combination of Purposes listed above 
apply, or where Material is to be used for a 
purpose not covered above 
6 Commencement Date: 7 Expiry Date: 
8 INSTITUTE 
Authorised 
Signatory 
Name: 
Position: 
Telephone:                                            Email: 
AG
R
EE
M
EN
T 
D
ET
AI
L 
9 Recipient’s 
Authorised 
Signatory 
Name: 
Position: 
Telephone:                                            Email: 
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By countersigning below, both parties agree to the Terms and Conditions of this Agreement and have provided 
the Details as required in Schedules 1, 2, and 3 
Dated this                   day of                                20__ Dated this                   day of                                20__ 
EX
EC
UT
IO
N 
CL
AU
SE
 
Signed for and on behalf of  INSTITUTE 
……………..……………………………………………….. 
Authorised Signatory (signature) 
……………………………………………………………… 
Witness (signature) 
………………………………………………………………  
Witness Name and Title 
……………………………………………………………… 
Manager Business Development (counter-signature) 
Signed for and on behalf of the Recipient 
……………..…………………………………………… 
Recipient Authorised Signatory (signature) 
………………………………………………………..... 
Recipient Witness (signature) 
………………………………………………………...... 
Recipient Witness Name and Title 
………………………………………………………….. 
Recipient Authorised counter-signatory, if applicable 
(signature) 
Office use only GMTA ID……………………… GMTA prepared by:…………………………. 
 
SCHEDULE 2: Further information describing the Material to be supplied 
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SCHEDULE 3: Further information describing the purposes for which the Material may be used 
and subsequent obligations of both parties 
1. Purpose(s) for which the Material may be used: 
2. Special conditions relating to the use of the Material: 
By countersigning below, both INSTITUTE and the Recipient’s Authorised Signatory have checked the 
information set out in Schedule 2 and 3 and any associated attachments and agree that all information is 
true and correct and in accordance with the wishes of their organization. 
Dated this                   day of                                    20__ Dated this                   day of                                   
20__ 
  SI
G
N
IN
G
 
………………………………………………………….… 
INSTITUTE Authorised Signatory (Signature) 
………………………………………………………  
Recipient Authorised Signatory (Signature) 
TERMS and CONDITIONS 
All Item numbers referred to in the Terms and Conditions refer to Items within Schedule 1, 2 or 3 
unless otherwise stated. 
By providing the Details and countersigning Schedule 1 and if applicable, providing 
further information and countersigning Schedule 2 and 3, both INSTITUTE and the 
Recipient agree to the following: 
1. GENERAL OBLIGATIONS 
1.1) The Recipient acknowledges it accepts the Material at its own risk and that INSTITUTE 
is supplying the Material without any expressed or implied warranty as to the utility of 
the Material for the Purpose  
1.2) INSTITUTE hereby grants the Recipient (Item 4 of Schedule 1) the right to use the 
Material (Item 1 of Schedule 1 or Schedule 2, as applicable) solely for the purposes 
defined in Item 5 of Schedule 1 or Item 1 of Schedule 3, as applicable.  
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1.3) The quantity and form of Material (Item 2 of Schedule 1) shall be delivered at 
INSTITUTE expense to the Delivery Address of the Recipient (Item 4 of Schedule 1) by 
the Delivery Date (Item 3 of Schedule 1) or as soon as practicable thereafter. 
1.4) The Recipient shall take all necessary precautions to ensure the security of the Material, 
including but not restricted to adequate confidential identification as mutually agreed. 
The Recipient must detail such security measures in reports as required in Clause 1.8. 
1.5) If the Recipient ceases to have a use for the Material, or if this Agreement expires or is 
terminated, or if INSTITUTE so requests, all Material shall be destroyed or returned to 
INSTITUTE (at INSTITUTE’s election) and evidence to INSTITUTE’s satisfaction of 
such destruction shall be immediately forwarded to INSTITUTE. 
1.6) INSTITUTE shall have access to the Material and the relevant trialling, testing, 
modification or experimenting sites and all associated results, information and data at any 
point in the duration of the Agreement, subject to reasonable notification being given by 
INSTITUTE to the Recipient. 
1.7) The transfer of any other material from the Recipient to INSTITUTE including, where 
applicable, crossbred breeding lines whose parent is the Material supplied by 
INSTITUTE will occur on the basis of like terms and conditions to those set out in this 
Agreement. 
1.8) The Recipient shall deliver to INSTITUTE an identical copy of all summary reports 
produced by the Recipient on the performance and security of the Material at least every 
twelve (12) months following the Commencement Date, for the duration of the 
agreement. 
2. DURATION OF THE AGREEMENT 
2.1) This agreement shall commence on the Commencement Date (Item 6 of Schedule 1) and 
expire on the Expiry Date (Item 7 of Schedule 1). The Recipient shall complete all 
obligations under this Agreement by the Expiry Date (Item 7 of Schedule 1). 
2.2) CONFIDENTIALITY 
2.3) For the duration of the Agreement and for a period of three (3) years thereafter 
INSTITUTE and the Recipient shall keep confidential all information in relation to the 
supplied Material and all subsequent testing, modifications or experiments in relation to 
the Material. Either party may reveal information within the confidentiality period upon 
written approval from the other party. 
2.4) Nothing in this Agreement prevents or inhibits INSTITUTE from providing information 
to the Minister of the Crown in right of the  COUNTRY having responsibility for the 
INSTITUTE.  Further, nothing in this Agreement prevents or inhibits that Minister of the 
Crown from providing to the Parliament of COUNTRY information concerning any 
conduct or operation of INSTITUTE in such a manner and to such an extent as the 
Minister thinks reasonable and appropriate. 
3. OWNERSHIP OF MATERIAL AND INTELLECTUAL PROPERTY  
4.1) Notwithstanding the Recipient’s right to use the Material to the purposes defined in Item 
5 and Item 1 of Schedule 3 as applicable, and unless Clauses 5.2 and/or 5.5 of this 
Agreement apply, the Recipient acknowledges and agrees that the Material and all 
associated industrial and intellectual property rights are owned in perpetuity by 
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INSTITUTE and the Material cannot be transferred by the Recipient to any third party, 
under any circumstances. 
4. SPECIFIC OBLIGATIONS 
4.2) The Recipient may only use the Material for the purposes set out in Item 5 of Schedule 1 
or Item 1 of Schedule 3 as applicable, and accordingly agrees to the following specific 
obligations: 
4.3) As parental material: If the Material is used in its supplied form as parental material for 
crossing with other genetic material being either breeding lines or commercial plant 
varieties (Purpose 1 of Item 5 of Schedule 1) the Recipient does not need any further 
approval for such activity. Provided that any new material is not considered to be 
essentially derived within the meaning of the Plant Breeder’s Rights Act 1994 (Cth), any 
new material that results from such crossing with other genetic material will be solely 
owned by the Recipient provided that the Recipient agrees that progeny derived from 
material received by INSTITUTE from the Recipient shall be owned solely INSTITUTE. 
INSTITUTE’s role in the parentage of the new material should be acknowledged in any 
subsequent trialling, modifying, Plant Breeders Rights registration or commercialization 
process. 
4.4) For reselection: If the Material is used for reselection purposes (Purpose 2 of Item 5 of 
Schedule 1) any new material that results from such reselection will be solely owned by 
INSTITUTE. Such new material cannot be modified, improved, experimented on, or 
commercialised without both parties entering into a meaningful agreement allowing such 
activity. 
4.5) For testing and evaluation: If the Material is used for testing and evaluation purposes 
(Purpose 3 of Item 5 of Schedule 1) the Recipient does not need any further approval for 
such activity. Any new material that results from such testing and evaluation shall be 
solely owned by INSTITUTE. Such new material cannot be modified, improved, 
experimented on, or commercialised without both parties entering into a meaningful 
agreement allowing such activity.  
4.6) For genetic manipulation: If the Material is used in its current form as genetic 
manipulation material for the insertion of extraneous deoxyribonucleic acid  or ‘DNA’ 
(Purpose 4 of Item 5 of Schedule 1) the Recipient does not need any further approval for 
such activity. Any new material that results from such genetic manipulation and DNA 
insertion, will be jointly owned by INSTITUTE and the Recipient. Such new material 
cannot be modified, improved, experimented on, or commercialised without both parties 
entering into a written agreement allowing such activity  
4.7) For some other purpose or combination of purposes: If the Material is used for any 
other single purpose or combined purposes (Purpose 5 of Item 5 of Schedule 1) as 
specified in Schedule 3 the Recipient shall meet all of the obligations set out in 
Schedule 3. 
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APPENDIX 4 
THE TERMS OF REFERENCE DEFINING THE SCOPE OF THE REVIEW 
Terms of Reference for a Consultant to conduct study on technical issues related to developing 
harmonized management policies, guidelines and practices concerning acquisition, use and 
distribution of Agricultural Microbial Genetic Resources (AMiGR) 
The consultant will: 
1. Participate in a research initiation brain-storming session, either in person or over the 
phone, with members of the Genetic Resources Policy Committee (GRPC), Inter-Center Working 
Group – Genetic Resources (ICWG-GR), FAO, MOSAICC and other interested parties 
concerning the research activities he or she will undertake;  
2. Address the question whether there is a distinct subset of microbial genetic resources that 
can be called microbial genetic resources for food and agriculture, or agricultural microbial 
genetic resource (AMiGR). In this context, the consultant will, among other things, consider data 
concerning the physical nature of AMiGR and their broad categories and uses,   the history and 
actual patterns of the distribution of AMiGR around the globe, and other possible factors that 
may distinguish AMiGR from other forms of MGRs, for example, those that are used for 
pharmaceutical or industrial purposes. It is understood that it is probably not possible to 
exhaustively define the outer limits of this sub-class of resources, given the highly dynamic 
nature of their various sources, uses and distribution. Of course, it also the case that some MGRs 
are used for both agricultural purposes and other purposes.  However, it is desirable to at least 
establish a ‘moving’ definition. We may also consider the use of the MGR as a discriminating 
factor (as for PGRFA).        
3. Conduct a survey of management policies, guidelines and practices of organizations 
concerning the acquisition, use, collection and distribution of AMiGR materials. In this context, 
the consultant will focus on:  
• Future Harvest Centres holding AMiGRs. Regarding the Future Harvest Centres, the 
consultant will use the System-wide Genetic Resources Program (SGRP) report entitled “A 
Discussion Paper on the Status of Microbial Genetic Resources Held by the CGIAR 
Centres,” by Dr Kenneth Street as a starting point. The consultant will also develop a 
questionnaire and circulate it through the SGRP of the CGIAR to obtain new data and critical 
reflections from AMiGR managers within the Future Harvest Centres; and 
• other organizations studying, holding or using similar AMiGRs, including the World 
Federation of Culture Collections, ICIPE, the United States’ Department of Agriculture, the 
Belgian Coordinated Collections of Micro-organisms (which coordinated the development of 
the Micro-Organisms Sustainable use and Access regulation International Code of Conduct 
(MOSAICC)), Biological Resource Centres as developed by the OECD, organizations that 
have developed codes of responsible behaviour for forestry plantation management 
concerning uses of MGRs, the International Union of Forest Research Organization 
(IUFRO), including working group 2.01.13 “Root physiology and symbiosis”, and so on. The 
consultant will identify a range of other similar AMiGR collection-holders and/or users 
whose management policies, guidelines or practices could usefully be reviewed in the context 
of this study.  
4. Address the following questions:  
• What are the basic needs and challenges in using these AMiGR in the general context of 
agricultural development for the next years? 
• What obstacles are countries having in using these AMiGR, (with a special emphasis on 
developing countries)? 
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• Are there informal (non-legalized) customs developed for the acquisition, distribution, and or 
exchanges of these AMiGR? Are there movements towards codification of those activities? 
In what direction are they moving and what kinds of organizations are generally involved in 
developing those codes? 
• Are the informal customs and movements towards codification with respect to these AMiGR 
different than those resources being used, e.g., biological control, bio fertilization, food 
industry, etc? If so, why?  
• Is there evidence that national access laws are having an impact on the transfer, use of, and 
research concerning, these resources? 
• What are the trends in patenting of unmodified and modified microbials? 
 
